Welcome!

News Feed Item

Drug Discovery Technologies - A Global Market Overview

NEW YORK, Sept. 1, 2014 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:  Drug Discovery Technologies - A Global Market Overview

http://www.reportlinker.com/p02349116/Drug-Discovery-Technologies---A-Global-Market-Overview.html

The development of new drugs for treating difficult diseases, such as cancer requires extensive expenditure, in addition to consuming a lot of time. The first step in designing a new drug involves the utilizing high-throughput screening of large chemical libraries for identifying compounds that can provide the requisite therapeutic effect. The capability of visualizing biological activity at the cellular level has constituted a strategic component in drug discovery, and adding automation and high-volume screening methods has enabled in testing compounds in large numbers. The field of pharmaceutical research is being provided considerable impetus through the combination of imaging and screening.

Worldwide market for drug discovery technologies explored in this study includes Bioanalytical Assays, Bioinformatics, Cell Based Assays, Genomic Technologies, High Throughput Screening, Proteomic Technologies and Others comprising Epigenetics, Metabolomics, Combinatorial Chemistry, Synthetic Biology, Systems Biology and Nanotechnology.

The global market value for the above mentioned technologies is analyzed in USD. High Throughput Screening accounts for a lion's share in global drug discovery technologies market with an expected share of about 30% in 2015 valued at $18 billion followed by Bioanalytical Assays or instruments by about $14 billion.

This 248 pages global market report includes 28 charts (includes a data table and graphical representation for each chart), supported with meaningful and easy to understand graphical presentation, of market numbers. This report profiles 56 key global players and 67 major players across the United States – 41; Europe – 16; Asia-Pacific – 7; and Rest of World - 3. The research also provides the listing of the companies that are engaged in technology, contract research services and providers of discovery technologies. The global list of companies covers addresses, contact numbers and the website addresses of 186 companies.

TABLE OF CONTENTS:

PART A: GLOBAL MARKET PERSPECTIVE

1. INTRODUCTION

1.1 Product Outline

1.1.1 Backdrop

1.1.2 What Is Drug Discovery?

1.1.2.1 Screening and Design

1.1.3 Omics in Drug Discovery and Development

1.1.4 Process of Discovering Improved Drugs Provided by a Technological Revolution

1.1.5 Drug Discovery Technologies

1.1.5.1 Bioanalytical Assays

1.1.5.1.1 Bio-Analytical Techniques

1.1.5.1.2 Sample Extraction

1.1.5.2 Bioinformatics

1.1.5.2.1 Computer-Aided Drug Design

1.1.5.3 Cell Based Assays

1.1.5.3.1 Cell-Based Assays in High-Throughput Screening for Drug Discovery

1.1.5.4 Genomic Technologies

1.1.5.4.1 Drug Discovery

1.1.5.4.2 Clinical Medicine

1.1.5.4.3 New Antibiotics

1.1.5.5 High Throughput Screening

1.1.5.5.1 High Throughput Screening in Drug Discovery

1.1.5.6 Proteomic Technologies

1.1.5.6.1 A Proteomics Approach to Biomarker Discovery and Drug Development

1.1.5.7 Other Technologies

1.1.5.7.1 Epigenetics

1.1.5.7.1.1 Epigenetics and Cancer Treatment

1.1.5.7.2 Metabolomics

1.1.5.7.2.1 Target Identification

1.1.5.7.2.2 Target Validation

1.1.5.7.2.3 Lead Optimization

1.1.5.7.2.4 Mode of Action

1.1.5.7.2.5 Preclinical Studies

1.1.5.7.2.6 Clinical Studies

1.1.5.7.2.7 Post-Approval Studies

1.1.5.7.2.8 Diagnostics

1.1.5.7.3 Combinatorial Chemistry

1.1.5.7.3.1 Chemical Encoding

1.1.5.7.3.2 Positional Encoding

1.1.5.7.3.3 Electronic Encoding

1.1.5.7.4 Synthetic Biology

1.1.5.7.5 Systems Biology

1.1.5.7.5.1 Computer Modelling

1.1.5.7.6 Nanotechnology

2. KEY MARKET TRENDS

2.1 Drug Discovery Gets Faster, Smarter and Cheaper

2.2 Drug Discovery Being Enabled through Halogen Bonds

2.3 Drug Discovery Bolstered by New Use for Stem Cells in Targeting ALS

2.4 Personalized Medicine: Advantage Patients, Disadvantage Drug Companies

2.5 Identification of Diagnostic and Therapeutic Targets Better Enabled by Combining Plasma Screening and Genetic Screening

2.6 Source of New Drug Category from Trapping Malaria Parasites inside Host Blood Cell

2.7 Fighting Malaria Drug Resistance through an Innovative Method

2.8 Drug Screening in 3D Using High-Throughput Chip

2.9 Drug Discovery Expedited through 3D Protein Mapping

2.10 Drug Discovery and Automated Cell Staining

2.11 Drug Discovery and Development for Complex Disease Targets to be Alleviated through a Computer Program

3. RECENT PATENTS IN DRUG DISCOVERY LANDSCAPE

USPTO Issues '979 Patent for Biohaven's Glutamate Modulating Agents to Treat GAD

Patents Issued for Suven's New Chemical Entities to treat Neurodegenerative Disorders

Japan Patent Office Approves Patent for C4XD's Technology

Additional Patents Issued on MorphoSys' Ylanthia in the US and in China

Sareum Receives a Patent for its Kinase Inhibitors in Japan

USPTO Grants Patent for Prima BioMed's CVac

Japan Patent Office Decides to Issue Patent for Marina's SMARTICLES® Nucleic Acid Delivery Technology

USPTO Grants a Patent in Regulus' Sarnow Patent Estate on microRNA Therapies to Treat HCV

USPTO Grants Patent for Kadimastem's Cell Technology

USPTO Grants a Novel Patent in Alnylam's McSwiggen Patent Estate

Suven Receives Patent Approval in the US for its Major Depressive Disorder Drug

Notice of Allowance for Canadian Patent Granted to VistaGen

Issue of Patent on Broad Institute's New Gene-Editing Method

US Patent Office Grants Patent for HUB's Method of Growing Organoids

Dyadic Granted US Patent for High Throughput Screening

US Patent Granted to Theranostics Health

Reveleris Flash Chromatography System Receives Patent from the Australian Patent Office

Sareum Receives Patent for one of its CHK1 Cancer Programme-related Inventions in the US

Lpath's iSONEP Receives Patent from USPTO

KeyGene Obtains Patent for High Throughput Screening in the US

BioInvent's F.I.R.S.T. Drug Discovery Technology Gets Patent in the US

Plasticell Receives Additional Patents for its CombiCult® Cell Culture Technology in the US, Europe, Australia and Singapore

EntomoPharm Receives Patent for its BBB Insect Model in Europe

Summit Gets Patent for Utrophin Modulator SMT C1100 in the US

USPTO Grants Patent to OncoMed for Methods of Treating Cancer with its Antibody Vantictumab

Novel Component of Phylomer® Peptide Platform Patented by Phylogica for Advanced Cell-Penetrating Drug Discovery

COTI Receives Two Newly Granted Patents for its Lead Oncology Asset in the US

4. KEY GLOBAL PLAYERS4-Antibody AGAbbott LaboratoriesAccelrys, Inc.Affymetrix Inc.Agilent Technologies Inc.Asahi Kasei Pharma CorporationAstrazeneca PlcAviva Biosciences Corp.Bayer Healthcare AGBD BiosciencesBeckman Coulter Inc.Biacore International ABBioanalytical Systems, Inc.Bio-Rad Laboratories, Inc.Boehringer Ingelheim GmbHBristol-Myers Squibb CompanyCaliper Life Sciences, Inc.Caprion Proteomics, Inc.Celera CorporationCelgene CorporationCharles River Laboratories International, Inc.Compugen Ltd.Decode Genetics, Inc.EMD Millipore CorporationEvotec AGGE Healthcare Ltd.Genedata AGHitgen LtdHudson Robotics, Inc.Illumina Inc.Incyte CorporationIsis Pharmaceuticals, Inc.Kyowa Hakko Kirin Co., Ltd.Luminex CorporationMaxcyte, IncMerck & Co., Inc.Millennium Pharmaceuticals, Inc.Molecular Devices, LLCMolecular Discovery Ltd.Molecular Discovery Systems Pty., Ltd.New England Biolabs, Inc.Novartis AGOsiris Therapeutics Inc.Perkinelmer, Inc.Promega CorporationQiagen N.V.Quantum PharmaceuticalsRoche Holding AGShimadzu CorporationSigma-Aldrich CorporationSri BiosciencesTecan Group Ltd.The National Center for Drug ScreeningThermo Fisher Scientific Inc.Viva Biotech LtdWaters Corp.

5. KEY BUSINESS TRENDS

Evotec Established Alliance with Eternygen on New Small Molecule Inhibitors Development

MRC Technology Partnered With Daiichi Sankyo to Discover New Drug Targets

Evotec, Debiopharm Group™ to Discover New Drugs to treat Cancer

Daiichi Sankyo Forms Alliance with UCSF on New Cures Development to Treat Neurodegenerative Diseases

Debut of a Synergetic Drug Discovery Project for 2014 by Daiichi Sankyo

Analgesic Drug Discovery and Development Collaboration Formed by Convergence and Evotec

MIT SBC, Pfizer Enter into a Three-Year Drug Discovery Research Alliance

Abide, Celgene Partners to Discover and Develop Novel Drugs to Treat Inflammation and Immunological Disorders

Novel Genetic Platform Having the Ability to Yield Natural Microbial Genomes

Johnson & Johnson Innovation Signs Novel Agreements with NEOMED and MaRS Innovation

Boehringer Ingelheim and Circuit Therapeutics Form Drug Discovery Research Pact for Three Years

Life Technologies and NCATS form RNAi Research Alliance to Enhance Novel Therapeutics Discovery

Novel Core Unit of USTAR and U of U Eases Pharmacological Therapeutic Development

JHL Biotech Inks Strategic Collaboration with Selexis to Develop Biologic Drugs

Bayer Offer Funding to the SGC for Expediting Drug Research

HitGen, the University of Manchester's Cancer Research UK Manchester Institute Drug Discovery Group and Cancer Research Technology Form Drug Discovery Pact

BioFocus, Boehringer Ingelheim Enter Into Drug Discovery Pact

Evotec Establishes Drug Discovery Alliance with Johnson & Johnson Innovation on AD Targets

Release of GE Healthcare Life Sciences' Novel Xuri™ Technology Family

4SC Discovery, CRELUX and AiCuris Form Drug Discovery Pact

Novel SLAP Technology for Drug Discovery Advancements

Inauguration of GE Healthcare Life Sciences Technology Laboratory at the UK's First Open Innovation Bioscience Campus

Debut of an "Open Innovation" Research Alliance by AstraZeneca and Taiwan's NRPB to Accelerate Drug Discovery

Asahi Kasei Pharma and Vernalis plc Collaborate to Discover Drugs for Autoimmune Diseases

Launch of Thermo Fisher Scientific's Novel Innovations at BioProcess International Conference and Exhibition

Adimab Establishes Alliance with Celgene on Multi-target Discovery

Eurofins Scientific, GE Healthcare Enter Pact on Drug Discovery Services

Debut of Boehringer Ingelheim and Polyphor into the Next Research Stage of their Alliance

Commercial Release of Agilent's RapidFire 365 High-Throughput Mass Spectrometry System

Zalicus Plans to Advance Clinical Development of Z944

Debut of Kinexus' DrugKiNET KnowledgeBase

Evotec Establishes Alliance with Harvard University to Develop Novel Antibacterial Agents

UCSF Turns to be the First Partner of Pfizer's CTI in Both Small-Molecule and Biologics Discovery

In-House Development of Various Novel Antiviral Drugs from Achillion

Launch of Thermo Fisher Scientific's Drug Discovery and Biopharma Production Innovations

Sareum Partners with SRI International for Advancing the Clinical Development of Tyrosine Kinase 2 Small Molecule Drug Discovery Program

Launch of Hudson Robotics' High Efficiency Screening, an Advanced Drug Discovery Technology

Accelrys Insight and Accelrys Insight for Excel Drug Discovery Softwares from Accelrys, Inc

Renewal of Evotec and Genentech's Drug Discovery Collaboration

Alchemia, AstraZeneca Form Multi-Target Drug Discovery Pact

RaQualia Establishes Research Alliance with Interprotein to Discover PPI Inhibitor

Collaborative Effort of Evotec and Ono Yields Novel Compounds for Preclinical Development

Galapagos Takeover Cangenix Assets

EMD Millipore's Novel Genomic Biomarker Services

Marketing of an Advanced Metabolite-Identification Platform by Agilent and Molecular Discovery

QuantiGene® ViewRNA Assay Platform-based Novel Cancer Biomarker Tests Co-developed by Affymetrix and MGH

Numerate and Merck Partnered to Discover Drug Leads for Cardiovascular Disease Target

Evotec Partners with IR Pharma to Offer Drug Discovery Solutions in the Area of Respiratory Diseases

6. GLOBAL MARKET OVERVIEW6.1. Global Market Overview by Technology6.1.1 Drug Discovery Technology Overview by Global Region6.1.1.1 Bioanalytical Assays6.1.1.2 Bioinformatics6.1.1.3 Cell Based Assays6.1.1.4 Genomic Technologies6.1.1.5 High Throughput Screening6.1.1.6 Proteomic Technologies6.1.1.7 Other Drug Discovery Technologies

PART B: REGIONAL MARKET PERSPECTIVE

REGIONAL MARKET OVERVIEW

1. THE UNITED STATES

1.1 United States Market Overview by Technology

1.2 Major Market Players

Abbott Laboratories

Accelrys, Inc.

Affymetrix Inc.

Agenus Inc.

Agilent Technologies Inc.

Albany Molecular Research, Inc.

Arqule Inc.

Aviva Biosciences Corp.

BD Biosciences

Beckman Coulter Inc.

Bioanalytical Systems, Inc.

Bio-Rad Laboratories, Inc.

Biovision, Inc.

Bristol-Myers Squibb Company

Bruker Corporation

Caliper Life Sciences, Inc.

Capital Genomix, Inc.

Celera Corporation

Celgene Corporation

Charles River Laboratories International, Inc.

Discoverx Corporation

Discovery Genomics, Inc.

EMD Millipore Corporation

Hudson Robotics, Inc.

Illumina Inc.

Incyte Corporation

Isis Pharmaceuticals, Inc.

Life Technologies Corporation

Luminex Corporation

Maxcyte, Inc

Merck & Co., Inc.

Millennium Pharmaceuticals, Inc.

Molecular Devices, LLC

New England Biolabs, Inc.

Osiris Therapeutics Inc.

Perkinelmer, Inc.

Promega Corporation

Sigma-Aldrich Corporation

SRI Biosciences

Thermo Fisher Scientific Inc.

Waters Corp.

2. EUROPE2.1 European Market Overview by Technology2.2 Major Market Players4-Antibody AG (Switzerland)Astrazeneca Plc (United Kingdom)Bayer Healthcare AG (Germany)Biacore International AB (Sweden)Biofocus Dpi, Ltd (United Kingdom)Boehringer Ingelheim GmbH (Germany)Decode Genetics, Inc. (Iceland)Evotec AG (Germany)GE Healthcare Ltd. (United Kingdom)Genedata AG (Switzerland)Molecular Discovery Ltd. (Italy)Novartis AG (Switzerland)Qiagen N.V. (The Netherlands)Quantum Pharmaceuticals (Russia)Roche Holding AG (Switzerland)Tecan Group Ltd. (Switzerland)

3. ASIA-PACIFIC

3.1 Asia-Pacific Market Overview by Technology

3.2 Major Market Players

Asahi Kasei Pharma Corporation (Japan)

Hitgen Ltd (China)

Kyowa Hakko Kirin Co., Ltd. (Japan)

Molecular Discovery Systems Pty., Ltd. (Australia)

Shimadzu Corporation (Japan)

The National Center for Drug Screening (China)

Viva Biotech Ltd (China)

4. REST OF WORLD4.1 Rest of World Market Overview by Technology4.2 Major Market PlayersCaprion Proteomics, Inc. (Canada)Compugen Ltd. (Israel)Pluristem Therapeutics Inc. (Israel)

PART C: GUIDE TO THE INDUSTRY

1. NORTH AMERICA

1.1 Canada

1.2 United States

2. EUROPE

2.1 Belgium

2.2 Denmark

2.3 France

2.4 Germany

2.5 Iceland

2.6 Ireland

2.7 Italy

2.8 Russia

2.9 Sweden

2.10 Switzerland

2.11 The Netherlands

2.12 The United Kingdom

3. ASIA-PACIFIC

3.1 Australia

3.2 China

3.3 India

3.4 Japan

3.5 Singapore

3.6 Taiwan

4. REST OF WORLD

4.1 Israel

PART D: ANNEXURE1. RESEARCH METHOLOGY2. FEEDBACK

Charts & Graphs

PART A: GLOBAL MARKET PERSPECTIVEChart 1: Global Drug Discovery Technologies Market Analysis (2010-2020) in USD MillionChart 2: Global Drug Discovery Technologies Market Analysis (2010-2020) by Discovery Technology – Bioanalytical Assays, Bioinformatics, Cell Based Assays, Genomic Technologies, High Throughput Screening, Proteomic Technologies and Other Technologies in USD MillionChart 3: Glance at 2010, 2015 and 2020 Global Drug Discovery Technologies Market Share (%) by Discovery Technology – Bioanalytical Assays, Bioinformatics, Cell Based Assays, Genomic Technologies, High Throughput Screening, Proteomic Technologies and Other TechnologiesChart 4: Global Market for Bioanalytical Assays in Drug Discovery (2010-2020) by Geographic Region – United States, Europe, Asia-Pacific and Rest of World in USD MillionChart 5: Glance at 2010, 2015 and 2020 Global Market Share of Bioanalytical Assays in Drug Discovery (%) by Geographic Region – United States, Europe, Asia-Pacific and Rest of WorldChart 6: Global Market for Bioinformatics in Drug Discovery (2010-2020) by Geographic Region – United States, Europe, Asia-Pacific and Rest of World in USD MillionChart 7: Glance at 2010, 2015 and 2020 Global Market Share of Bioinformatics in Drug Discovery (%) by Geographic Region – United States, Europe, Asia-Pacific and Rest of WorldChart 8: Global Market for Cell Based Assays in Drug Discovery (2010-2020) by Geographic Region – United States, Europe, Asia-Pacific and Rest of World in USD MillionChart 9: Glance at 2010, 2015 and 2020 Global Market Share of Cell Based Assays in Drug Discovery (%) by Geographic Region – United States, Europe, Asia-Pacific and Rest of WorldChart 10: Global Market for Genomic Technologies in Drug Discovery (2010-2020) by Geographic Region – United States, Europe, Asia-Pacific and Rest of World in USD MillionChart 11: Glance at 2010, 2015 and 2020 Global Market Share of Genomic Technologies in Drug Discovery (%) by Geographic Region – United States, Europe, Asia-Pacific and Rest of WorldChart 12: Global Market for High Throughput Screening in Drug Discovery (2010-2020) by Geographic Region – United States, Europe, Asia-Pacific and Rest of World in USD MillionChart 13: Glance at 2010, 2015 and 2020 Global Market Share of High Throughput Screening in Drug Discovery (%) by Geographic Region – United States, Europe, Asia-Pacific and Rest of WorldChart 14: Global Market for Proteomic Technologies in Drug Discovery (2010-2020) by Geographic Region – United States, Europe, Asia-Pacific and Rest of World in USD MillionChart 15: Glance at 2010, 2015 and 2020 Global Market Share of Proteomic Technologies in Drug Discovery (%) by Geographic Region – United States, Europe, Asia-Pacific and Rest of WorldChart 16: Global Market for Other Drug Discovery Technologies in Drug Discovery (2010-2020) by Geographic Region – United States, Europe, Asia-Pacific and Rest of World in USD MillionChart 17: Glance at 2010, 2015 and 2020 Global Market Share of Other Drug Discovery Technologies in Drug Discovery (%) by Geographic Region – United States, Europe, Asia-Pacific and Rest of World

PART B: REGIONAL MARKET PERSPECTIVE

Chart 18: The Projection of Largest Regions in terms of Market Growth for Drug Discovery Technologies by Geography – Asia-Pacific, Europe and United States

Chart 19: Global Drug Discovery Technologies Market Analysis (2010-2020) by Geographic Region – United States, Europe, Asia-Pacific and Rest of World in USD Million

Chart 20: Glance at 2010, 2015 and 2020 Global Drug Discovery Technologies Market Share (%) by Geographic Region – United States, Europe, Asia-Pacific and Rest of World

THE UNITED STATESChart 21: United States Drug Discovery Technologies Market Analysis (2010-2020) by Discovery Technology – Bioanalytical Assays, Bioinformatics, Cell Based Assays, Genomic Technologies, High Throughput Screening, Proteomic Technologies and Other Technologies in USD MillionChart 22: Glance at 2010, 2015 and 2020 United States Drug Discovery Technologies Market Share (%) by Discovery Technology – Bioanalytical Assays, Bioinformatics, Cell Based Assays, Genomic Technologies, High Throughput Screening, Proteomic Technologies and Other Technologies

EUROPE

Chart 23: European Drug Discovery Technologies Market Analysis (2010-2020) by Discovery Technology – Bioanalytical Assays, Bioinformatics, Cell Based Assays, Genomic Technologies, High Throughput Screening, Proteomic Technologies and Other Technologies in USD Million

Chart 24: Glance at 2010, 2015 and 2020 European Drug Discovery Technologies Market Share (%) by Discovery Technology – Bioanalytical Assays, Bioinformatics, Cell Based Assays, Genomic Technologies, High Throughput Screening, Proteomic Technologies and Other Technologies

ASIA-PACIFICChart 25: Asia-Pacific Drug Discovery Technologies Market Analysis (2010-2020) by Discovery Technology – Bioanalytical Assays, Bioinformatics, Cell Based Assays, Genomic Technologies, High Throughput Screening, Proteomic Technologies and Other Technologies in USD MillionChart 26: Glance at 2010, 2015 and 2020 Asia-Pacific Drug Discovery Technologies Market Share (%) by Discovery Technology – Bioanalytical Assays, Bioinformatics, Cell Based Assays, Genomic Technologies, High Throughput Screening, Proteomic Technologies and Other Technologies

REST OF WORLD

Chart 27: Rest of World Drug Discovery Technologies Market Analysis (2010-2020) by Discovery Technology – Bioanalytical Assays, Bioinformatics, Cell Based Assays, Genomic Technologies, High Throughput Screening, Proteomic Technologies and Other Technologies in USD Million

Chart 28: Glance at 2010, 2015 and 2020 Rest of World Drug Discovery Technologies Market Share (%) by Discovery Technology – Bioanalytical Assays, Bioinformatics, Cell Based Assays, Genomic Technologies, High Throughput Screening, Proteomic Technologies and Other Technologies

Table 1: Prominent Technologies used for Bioanalytical ResearchTable 2: Prominent Types of Cell Based Assays used in High Throughput Screening

To order this report:  Drug Discovery Technologies - A Global Market Overview

http://www.reportlinker.com/p02349116/Drug-Discovery-Technologies---A-Global-Market-Overview.html 

__________________________
Contact Clare: [email protected]
US: (339)-368-6001
Intl: +1 339-368-6001

SOURCE Reportlinker

More Stories By PR Newswire

Copyright © 2007 PR Newswire. All rights reserved. Republication or redistribution of PRNewswire content is expressly prohibited without the prior written consent of PRNewswire. PRNewswire shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.

Latest Stories
More and more brands have jumped on the IoT bandwagon. We have an excess of wearables – activity trackers, smartwatches, smart glasses and sneakers, and more that track seemingly endless datapoints. However, most consumers have no idea what “IoT” means. Creating more wearables that track data shouldn't be the aim of brands; delivering meaningful, tangible relevance to their users should be. We're in a period in which the IoT pendulum is still swinging. Initially, it swung toward "smart for smart...
DevOps is often described as a combination of technology and culture. Without both, DevOps isn't complete. However, applying the culture to outdated technology is a recipe for disaster; as response times grow and connections between teams are delayed by technology, the culture will die. A Nutanix Enterprise Cloud has many benefits that provide the needed base for a true DevOps paradigm. In his general session at 20th Cloud Expo, Chris Brown, a Solutions Marketing Manager at Nutanix, will explore...
Tricky charts and visually deceptive graphs often make a case for the impact IT performance has on business. The debate isn't around the obvious; of course, IT performance metrics like website load time influence business metrics such as conversions and revenue. Rather, this presentation will explore various data analysis concepts to understand how, and how not to, assert such correlations. In his session at 20th Cloud Expo, Leo Vasiliou, Director of Web Performance Engineering at Catchpoint Sys...
Growth hacking is common for startups to make unheard-of progress in building their business. Career Hacks can help Geek Girls and those who support them (yes, that's you too, Dad!) to excel in this typically male-dominated world. Get ready to learn the facts: Is there a bias against women in the tech / developer communities? Why are women 50% of the workforce, but hold only 24% of the STEM or IT positions? Some beginnings of what to do about it! In her Day 2 Keynote at 17th Cloud Expo, Sandy Ca...
The buzz continues for cloud, data analytics and the Internet of Things (IoT) and their collective impact across all industries. But a new conversation is emerging - how do companies use industry disruption and technology enablers to lead in markets undergoing change, uncertainty and ambiguity? Organizations of all sizes need to evolve and transform, often under massive pressure, as industry lines blur and merge and traditional business models are assaulted and turned upside down. In this new da...
SYS-CON Events announced today that Technologic Systems Inc., an embedded systems solutions company, will exhibit at SYS-CON's @ThingsExpo, which will take place on June 6-8, 2017, at the Javits Center in New York City, NY. Technologic Systems is an embedded systems company with headquarters in Fountain Hills, Arizona. They have been in business for 32 years, helping more than 8,000 OEM customers and building over a hundred COTS products that have never been discontinued. Technologic Systems’ pr...
DevOps is often described as a combination of technology and culture. Without both, DevOps isn't complete. However, applying the culture to outdated technology is a recipe for disaster; as response times grow and connections between teams are delayed by technology, the culture will die. A Nutanix Enterprise Cloud has many benefits that provide the needed base for a true DevOps paradigm.
SYS-CON Events announced today that LeaseWeb USA, a cloud Infrastructure-as-a-Service (IaaS) provider, will exhibit at the 19th International Cloud Expo, which will take place on November 1–3, 2016, at the Santa Clara Convention Center in Santa Clara, CA. LeaseWeb is one of the world's largest hosting brands. The company helps customers define, develop and deploy IT infrastructure tailored to their exact business needs, by combining various kinds cloud solutions.
Unsecured IoT devices were used to launch crippling DDOS attacks in October 2016, targeting services such as Twitter, Spotify, and GitHub. Subsequent testimony to Congress about potential attacks on office buildings, schools, and hospitals raised the possibility for the IoT to harm and even kill people. What should be done? Does the government need to intervene? This panel at @ThingExpo New York brings together leading IoT and security experts to discuss this very serious topic.
Data is the fuel that drives the machine learning algorithmic engines and ultimately provides the business value. In his session at Cloud Expo, Ed Featherston, a director and senior enterprise architect at Collaborative Consulting, discussed the key considerations around quality, volume, timeliness, and pedigree that must be dealt with in order to properly fuel that engine.
SYS-CON Events announced today that Catchpoint Systems, Inc., a provider of innovative web and infrastructure monitoring solutions, has been named “Silver Sponsor” of SYS-CON's DevOps Summit at 18th Cloud Expo New York, which will take place June 7-9, 2016, at the Javits Center in New York City, NY. Catchpoint is a leading Digital Performance Analytics company that provides unparalleled insight into customer-critical services to help consistently deliver an amazing customer experience. Designed ...
LogMeIn has completed its previously disclosed merger with Citrix Systems, Inc.’s GetGo, Inc. subsidiary, a wholly owned subsidiary consisting of Citrix’s GoTo family of service offerings. The merger officially closed after market hours on January 31, 2017. Effected through a Reverse Morris Trust transaction, the merger brings together two of the preeminent players in cloud connectivity to instantly create one of the world’s top 10 public SaaS companies, and a market leader with the scale, resou...
DevOps tends to focus on the relationship between Dev and Ops, putting an emphasis on the ops and application infrastructure. But that’s changing with microservices architectures. In her session at DevOps Summit, Lori MacVittie, Evangelist for F5 Networks, will focus on how microservices are changing the underlying architectures needed to scale, secure and deliver applications based on highly distributed (micro) services and why that means an expansion into “the network” for DevOps.
SYS-CON Events announced today that Hitrons Solutions will exhibit at the 19th International Cloud Expo, which will take place on November 1–3, 2016, at the Santa Clara Convention Center in Santa Clara, CA. Hitrons Solutions Inc. is distributor in the North American market for unique products and services of small and medium-size businesses, including cloud services and solutions, SEO marketing platforms, and mobile applications.
Ayehu provides IT Process Automation & Orchestration solutions for IT and Security professionals to identify and resolve critical incidents and enable rapid containment, eradication, and recovery from cyber security breaches. Ayehu provides customers greater control over IT infrastructure through automation. Ayehu solutions have been deployed by major enterprises worldwide, and currently, support thousands of IT processes across the globe. The company has offices in New York, California, and Isr...